These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36993057)

  • 1. Epidemiology of mucormycosis in post-COVID-19 patients treated in a tertiary care hospital, Visakhapatnam, Andhra Pradesh.
    Manda VV; Patruni M; Nagendra MB; Bharthi MS; Nagappa V; Kurumella HS
    J Family Med Prim Care; 2022 Nov; 11(11):6995-7000. PubMed ID: 36993057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Serum Ferritin an Early Marker for COVID-19-Associated Mucormycosis?
    Dp I; Yadhav Ml K; Gs C
    Cureus; 2023 Mar; 15(3):e36734. PubMed ID: 37123703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
    Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
    Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Mucormycosis Cases During the Second Wave of COVID-19 in a Tertiary Care Institute in Western Rajasthan, India.
    Kumar A; Verma M; Hakim A; Sharma S; Meena R; Bhansali S
    Cureus; 2022 Mar; 14(3):e22973. PubMed ID: 35415040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on the Mucormycosis Outbreak: A Deadly Fungal Infection That Followed the COVID-19 Pandemic.
    Patel SN; Shah S; Panchal J; Desai C; Upadhya IB; Patel M
    Cureus; 2023 Feb; 15(2):e35095. PubMed ID: 36938207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.
    Vijayasekhar MV; Nagappa V; Swaroop KH; Mithun G; Achuith E; Varaprasad KS
    Neurol India; 2022; 70(3):1052-1056. PubMed ID: 35864638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological association of mucormycosis in COVID 19 pandemic.
    Varshney M; Saxena A; Binnani N; Kumar V; Vyas SP
    Indian J Pathol Microbiol; 2023; 66(1):101-105. PubMed ID: 36656219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
    Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
    Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mystery of Mucormycosis in COVID-19: A Multifactorial Menace or an Enigmatic Delta Variant Associated Phenomenon? An Exploratory Study from a Tertiary Care Centre in North India with a Brief Literature Review.
    Kalita D; Bhatia M; Rekha US; Singh A
    J Pharm Bioallied Sci; 2022; 14(1):46-51. PubMed ID: 35784107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
    Wasiq M; K R; Gn A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and Covid Associated Mucormucormycosis-A Cross Sectional Study in Kilpauk Medical College.
    Pradeepkumar V
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucormycosis and COVID-19: An epidemic within a pandemic in India.
    Selarka L; Sharma S; Saini D; Sharma S; Batra A; Waghmare VT; Dileep P; Patel S; Shah M; Parikh T; Darji P; Patel A; Goswami G; Shah A; Shah S; Lathiya H; Shah M; Sharma P; Chopra S; Gupta A; Jain N; Khan E; Sharma VK; Sharma AK; Chan ACY; Ong JJY
    Mycoses; 2021 Oct; 64(10):1253-1260. PubMed ID: 34255907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics of 100 Patients With COVID-19-Associated Mucormycosis From a Tertiary Care Center in North India.
    Kant R; Totaganti M; Mohan B; Bairwa M; Panda PK; Tyagi A; Prasad A; Bahurupi Y
    Cureus; 2022 Jun; 14(6):e25652. PubMed ID: 35800201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe.
    Farooq S; Khan NA; Singh A; Khan A; Sharma P; Meena R; Jakhar A; Kumar M; Kochar A
    Cureus; 2023 Jun; 15(6):e41010. PubMed ID: 37519583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, Clinical Features and Management of Rhino Orbital Mucormycosis in Post COVID 19 Patients.
    Desai EJ; Pandya A; Upadhya I; Patel T; Banerjee S; Jain V
    Indian J Otolaryngol Head Neck Surg; 2022 Mar; 74(1):103-107. PubMed ID: 34414101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.
    Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ
    Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
    Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Mucormycosis: A Black Fungus Disaster?
    Chillana S; Mohit Chilana KA
    Indian J Dermatol; 2022; 67(5):535-538. PubMed ID: 36865825
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.